<u id="etjdy"></u>
<u id="etjdy"><sub id="etjdy"></sub></u>
<center id="etjdy"></center>
<address id="etjdy"><kbd id="etjdy"></kbd></address>
<sup id="etjdy"></sup>
<pre id="etjdy"></pre>

    <u id="etjdy"><mark id="etjdy"></mark></u>
    <video id="etjdy"><input id="etjdy"><big id="etjdy"></big></input></video>


    Recombinant Human IL-13|重組人白介素-13變體

    產品名稱: Recombinant Human IL-13|重組人白介素-13變體
    產品型號: C22-101-13
    產品展商: PERFEMIKER
    產品文檔: 無相關文檔


    Recombinant Human IL-13|重組人白介素-13變體 現貨促銷,>96% by SDS-PAGE and HPLC analyses.

    Recombinant Human IL-13|重組人白介素-13變體  的詳細介紹

    產品名稱:Recombinant Human IL-13|重組人白介素-13變體

    單   位:

    Recombinant Human IL-13|重組人白介素-13變體,國產細胞因子,cytokine

    C22-101-13   2μg/¥500   10μg/¥1000   1mg/詢價

    >96% by SDS-PAGE and HPLC analyses.

    Biological Activity:

    Fully biologically active when compared to standard. The ED50 as determined by the dose-dependent proliferation of TF-1 cells was < 1.0 ng/ml, corresponding to a specific activity of > 1 x 106 units/mg.

    This lyophilized preparation is stable at 2-8°C, but should be kept at -20°C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8°C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20°C to -70°C. Avoid repeated freeze/thaw cycles.

    滬公網安備 31011402005168號